SOHAIL MERCHANT
Allopathic & Osteopathic Physicians|Family Medicine ORLANDO, FL NPI 1275160939
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine FL GlaxoSmithKline, LLC. All categories
General Payments — all program years on this page
$474.96
- Category: General Payments
- Program years: PY2022–2024
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $363.79 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $363.79 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $136.68 | 2 |
| SANOFI-AVENTIS U.S. LLC | $114.90 | 1 |
| Phadia US Inc. | $38.65 | 2 |
| PFIZER INC. | $35.84 | 2 |
| Merck Sharp & Dohme Corporation | $19.66 | 1 |
| Supernus Pharmaceuticals, Inc. | $18.06 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1067586638 | Phadia US Inc. | $21.73 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1067586640 | Phadia US Inc. | $16.92 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116372581 | GlaxoSmithKline, LLC. | $124.00 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116448256 | GlaxoSmithKline, LLC. | $12.68 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131907057 | PFIZER INC. | $17.41 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131916166 | PFIZER INC. | $18.43 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139586240 | SANOFI-AVENTIS U.S. LLC | $114.90 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141911666 | Merck Sharp & Dohme LLC | $19.66 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147895319 | Supernus Pharmaceuticals, Inc. | $18.06 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.